Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2Smoking Cessation 1Smoking 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Colonic Neoplasms 1Chronic Disease 1Breast Carcinoma In Situ 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79pembrolizumab 75Bevacizumab 75Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Neoplasms × Health × Clear all
NCT06058312 2026-04-30

MyPrefMed

Centre Antoine Lacassagne

Phase NA Completed
116 enrolled
Tumor-Agnostic

Neoplasms

NCT03446092 2022-05-12

Mindfulness for People With Incurable Cancer

Lancaster University

Phase NA Completed
3 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡